Market Closed -
BME
09:05:12 08/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
2.475
EUR
|
+0.20%
|
|
+8.79%
|
-28.09%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,206
|
565.7
|
375
|
313.7
|
225
|
-
|
-
|
Enterprise Value (EV)
1 |
1,188
|
637.6
|
375
|
534.1
|
557
|
675.5
|
663.5
|
P/E ratio
|
-176
x
|
-516
x
|
26.5
x
|
-
|
5.29
x
|
6.35
x
|
5.71
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
13.5%
|
3.23%
|
Capitalization / Revenue
|
5.12
x
|
1.63
x
|
0.66
x
|
0.53
x
|
0.33
x
|
0.32
x
|
0.27
x
|
EV / Revenue
|
5.04
x
|
1.84
x
|
0.66
x
|
0.91
x
|
0.83
x
|
0.96
x
|
0.79
x
|
EV / EBITDA
|
-126
x
|
-92.8
x
|
11.5
x
|
9.45
x
|
5.94
x
|
7.56
x
|
6.94
x
|
EV / FCF
|
-28.5
x
|
-8.13
x
|
-
|
-
|
-4.6
x
|
-5.86
x
|
-11.5
x
|
FCF Yield
|
-3.5%
|
-12.3%
|
-
|
-
|
-21.7%
|
-17.1%
|
-8.68%
|
Price to Book
|
8.47
x
|
3.82
x
|
-
|
-
|
1.35
x
|
1.15
x
|
0.9
x
|
Nbr of stocks (in thousands)
|
91,387
|
91,387
|
90,848
|
91,145
|
90,921
|
-
|
-
|
Reference price
2 |
13.20
|
6.190
|
4.128
|
3.442
|
2.475
|
2.475
|
2.475
|
Announcement Date
|
25/02/21
|
24/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
356.8
|
235.6
|
346.5
|
568.2
|
587.2
|
673.2
|
704.1
|
837
|
EBITDA
1 |
-
|
-9.408
|
-6.873
|
32.64
|
56.53
|
93.78
|
89.32
|
95.67
|
EBIT
1 |
-
|
-17.58
|
-13.42
|
22.71
|
32.88
|
77.75
|
70.24
|
73.33
|
Operating Margin
|
-
|
-7.46%
|
-3.87%
|
4%
|
5.6%
|
11.55%
|
9.98%
|
8.76%
|
Earnings before Tax (EBT)
1 |
-
|
-10.77
|
-5.506
|
18.08
|
13.74
|
65
|
50
|
51
|
Net income
1 |
-
|
-4.918
|
-1.167
|
13.06
|
11.72
|
42.78
|
35.02
|
37.8
|
Net margin
|
-
|
-2.09%
|
-0.34%
|
2.3%
|
2%
|
6.35%
|
4.97%
|
4.52%
|
EPS
2 |
0.0890
|
-0.0750
|
-0.0120
|
0.1560
|
-
|
0.4675
|
0.3900
|
0.4333
|
Free Cash Flow
1 |
-
|
-41.65
|
-78.41
|
-
|
-
|
-121
|
-115.3
|
-57.6
|
FCF margin
|
-
|
-17.67%
|
-22.63%
|
-
|
-
|
-17.98%
|
-16.38%
|
-6.88%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0.3333
|
0.0800
|
Announcement Date
|
24/06/20
|
25/02/21
|
24/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 S1
|
---|
Net sales
|
-
|
99.9
|
-
|
138.4
|
244.5
|
-
|
-
|
184.5
|
EBITDA
1 |
-19.12
|
-3.426
|
15.7
|
-
|
-5.086
|
13.6
|
24.15
|
-10.18
|
EBIT
1 |
-
|
-3.986
|
13.18
|
-
|
-10.16
|
6.227
|
20.46
|
-17.84
|
Operating Margin
|
-
|
-3.99%
|
-
|
-
|
-4.16%
|
-
|
-
|
-9.67%
|
Earnings before Tax (EBT)
1 |
-27.33
|
0.684
|
21.14
|
-4.76
|
-9.519
|
14.37
|
13.22
|
-21.93
|
Net income
1 |
-19.86
|
-0.1
|
18.8
|
-
|
-9.962
|
14.48
|
8.548
|
-14.4
|
Net margin
|
-
|
-0.1%
|
-
|
-
|
-4.07%
|
-
|
-
|
-7.81%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/09/21
|
04/11/21
|
24/02/22
|
15/09/22
|
15/09/22
|
15/11/22
|
28/02/23
|
26/09/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
71.9
|
-
|
220
|
332
|
451
|
439
|
Net Cash position
1 |
-
|
18
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-10.46
x
|
-
|
3.899
x
|
3.54
x
|
5.043
x
|
4.584
x
|
Free Cash Flow
1 |
-
|
-41.6
|
-78.4
|
-
|
-
|
-121
|
-115
|
-57.6
|
ROE (net income / shareholders' equity)
|
-
|
-3.7%
|
-0.81%
|
8.43%
|
7.65%
|
22.5%
|
15.4%
|
16.4%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
2.53%
|
1.82%
|
8.4%
|
3.8%
|
3.5%
|
Assets
1 |
-
|
-
|
-
|
516.4
|
644.8
|
509.2
|
921.7
|
1,080
|
Book Value Per Share
2 |
-
|
1.560
|
1.620
|
-
|
-
|
1.830
|
2.160
|
2.750
|
Cash Flow per Share
|
-
|
-0.5200
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
7.54
|
95.5
|
-
|
-
|
115
|
140
|
53
|
Capex / Sales
|
-
|
3.2%
|
27.57%
|
-
|
-
|
17.14%
|
19.94%
|
6.33%
|
Announcement Date
|
24/06/20
|
25/02/21
|
24/02/22
|
28/02/23
|
28/02/24
|
-
|
-
|
-
|
Last Close Price
2.475
EUR Average target price
4.517
EUR Spread / Average Target +82.49% Consensus |